Newsroom


Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.
12

Bausch + Lomb Booth to Feature Wet Lab During the Annual Meeting of the American Academy of Ophthalmology in Chicago

For the First Time at AAO, Attendees Invited to “Test Drive” the Company’s Surgical Products

FOR RELEASE WEDNESDAY, OCTOBER 12, 2016

BRIDGEWATER, NJ – Bausch + Lomb, a leading global eye health company, today announced that, for the first time at the Annual Meeting of the American Academy of Ophthalmology (AAO) (Oct. 15-18), attendees will have the opportunity to “test drive” it’s latest innovations at a wet lab in the company’s AAO booth (#3026).

 

“We are thrilled to offer our customers such a unique opportunity for the first time ever at AAO,” said Chuck Hess, vice president and general manager, U.S. Surgical, Bausch + Lomb. “We understand how important it is for surgeons to have the chance to experience a product before they can decide what’s right for them and for their patients, and we believe that once they have the chance to ‘test drive’ our products, they will immediately recognize the advantages they offer.”

 

During interactive 30-minute sessions, surgeons will gain real time, hands-on experience with the company’s robust surgical product portfolio, including the Stellaris Elite™ platform, a next generation innovative model for both vitreoretinal and cataract surgery in a single system, anticipated to launch in 2017.  Unlike traditional large capital equipment, which typically has decade-long life cycles, the Stellaris Elite will offer surgeons a platform that provides innovative upgrades and enhancements every one to two years. The new technology will be developed to grow with surgeons and their practices over time, bolstering their existing technology to provide optimal long-term visual outcomes for their patients.

 

Also available for test drive will be the VICTUS® femtosecond laser and many of the company’s intraocular lenses (IOLs) and delivery systems, which include the enVista®, Crystalens® AO, TRULIGN® Toric IOLs, and the iSert® delivery system, the market-leading preloaded IOL. Attendees will have the opportunity to hear firsthand from the engineers and researchers who are responsible for the development of Bausch + Lomb’s surgical suite of technologies and learn pearls and techniques from their peers. 

 

Attendees are also invited to attend a series of instructional courses led by a distinguished group of speakers in the Bausch + Lomb booth. The courses will focus on a variety of topics including corneal refractive screening and femtosecond LASIK pearls.

 

The full schedule includes:   

 

Saturday, October 15

11:00-Noon: “enVista® IOL: The Clearer Choice” by Anil Shivaram, M.D.;

  • 1:00-2:00 p.m.: “Why I Choose Stellaris® Vision Enhancement System As My Phaco Machine of Choice” by I. Paul Singh, M.D.;
  • 2:00-3:00 p.m. “FLACS – A Glaucoma Specialist’s Perspective” by I. Paul Singh, M.D.;
  • 2:30-3:30 p.m.: “A Novel Entry System for Posterior Surgery” by Brandon Busbee, M.D.


Sunday, October 16

  • 10:00-11:00 a.m.: “Why I Choose Stellaris® Vision Enhancement System As My Phaco Machine of Choice” by Robert Weinstock, M.D.;
  • 11:00-11:30 a.m.: “Corneal-Refractive Screening for the General Ophthalmologist” by Michael Endl, M.D.;
  • 11:00 a.m.-Noon: “Performing 27ga. Posterior Surgery with Stellaris Elite® Platform” by Asheesh Tewari, M.D.;
  • 11:30 a.m.-Noon: “Femtosecond LASIK Flap Pearls; Understanding Various Methods of Flap Creation and Management” by Michael Endl, M.D.;
  • 11:30 a.m.-12:30 p.m.: “Crystalens® IOL/Trulign® IOL” Accommodating an Active Lifestyle” by P. Dee Stephenson, M.D.;
  • 2:00-3:00 p.m.:  “The Power of Venturi” by Farrell “Toby” Tyson, M.D.


Monday, October 17

  • 10:00-10:30 a.m.: “Corneal-Refractive Screening for the General Ophthalmologist” by Michael Endl, M.D.;
  • 10:30-11:00 a.m.: “Femtosecond LASIK Flap Pearls: Understanding Various Methods of Flap Creation and Management” by Michael Endl, M.D.;
  • 10:30-11:30 a.m.: “Advances in Posterior Illumination” by Sunil Srivastava, M.D.;
  • 12:30-1:30 p.m.: “iSert® IOL: Innovation and Efficiency in Your Hand” by William Wiley, M.D.

 

For more information and to schedule an appointment in the wet lab to visit: www.testdrivebausch.com 

 

Featured Retina-Focused Event

Bausch + Lomb invites vitreoretinal surgeons to attend “The Retina Sessions,” which will take place on Friday, October 14 from 7-10 p.m. at the Sidney R. Yates Gallery located in the Chicago Cultural Center (78 E. Washington Street). During the session, surgeons will have the opportunity to interact with a panel of experts (moderator: Asheesh Tewari, M.D.; and faculty: John W. Kitchens, M.D.; Gaurav K. Shah, M.D.; Sunir J. Garg, M.D.; and Kevin. J. Blinder, M.D.) as they analyze video of challenging surgical cases. Surgeons can register to attend the event at www.TheRetinaSessions-Chicago.com

 

Scientific Podium Presentations and Posters

Clinical data from the Bausch + Lomb Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study, the only ongoing nationwide program that monitors the in vitro potency of a variety of common antibiotics against ocular pathogens, and glaucoma candidate, latanoprostene bunod ophthalmic solution 0.024%, will be featured in various podium presentations and posters.

 

The full schedule includes:


Monday, October 17


Asbell, Penny A. “From TRUST to ARMOR.” [AAO Podium Presentation PA037: OP04 Cornea, External Disease (Hyatt McCormick Place), Monday, Oct. 17, 8:42 to 8:49 a.m. CST].

Peace, James H. “Latanoprostene bunod ophthalmic solution 0.024% for IOP lowering in glaucoma: responder rates in Phase 3 studies.”  [AAO Poster  PO399: Hall A (Hyatt McCormick Place), Monday, Oct. 17, 12:30 to 2 p.m. CST].

Supporting Eye Tissue Donation in the 31st Annual Run for Vision

On Sunday, Oct. 16 at 6:30 a.m. CST, AAO attendees are invited to join donor family members and corneal transplant recipients for the annual Run for Vision, a 5k benefit run/walk, which will begin at Grant Park at Upper Hutchinson Field (the southwest corner of Columbus and Balbo Drives). Bausch + Lomb has been a proud supporter of this event for more than 30 years to help raise awareness and support eye tissue donation on behalf of the Eye Bank Association of America (EBAA).   

AAO attendees can register at the Bausch + Lomb Booth (#3026) during the conference or online by Thursday, Oct. 13
here. Pre-registered runners and walkers can pick up their race packets, including runner bib and a technologically-enhanced t-shirt, at McCormick Place (2301 S. Dr. Martin Luther King Jr. Blvd) between 9 a.m. and 5 p.m. CST on Saturday, Oct. 15.

About Bausch + Lomb
Bausch + Lomb, a Valeant Pharmaceuticals International, Inc. company, is a leading global eye health organization that is solely focused on protecting, enhancing and restoring people’s eyesight. Its core businesses include over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries.

®/™ are trademarks of Bausch & Lomb or its affiliates. iSert is a trademark of Hoya Surgical Optics GmbH. Any other product/brand names are trademarks of their respective owners. © 2016 Bausch & Lomb Incorporated. CRS.0068.USA.16.  


News Media Contacts
Kristy Marks

Sr. Manager, Communications, Bausch + Lomb

(908) 927-0683 or kristy.marks@bausch.com


Teresa Panas
BioComm Network, on behalf of Bausch + Lomb
(973) 809-8590 or tpanas@biocommnetwork.com

Actions: E-mail | Permalink |